As reported by NutraIngredients-USA, the company’s dileucine ingredient – branded RAMPS (Rapid Action Muscle Protein Synthesis) – was the subject of a paper published in the Journal of Applied Physiology, which reported that young men who consumed dileucine had significantly more muscle synthesis than men who ingested only leucine.
“When we talk about leucine, this has been the gold-standard for onset of muscle protein synthesis, meaning anabolism, meaning the creation or maintenance of muscle. Obviously, this is important to body building but also sarcopenia, cachexia, these conditions where we’re losing muscle or where muscle is of great clinical importance,” said Shawn Wells, who co-founded ING2 in 2018 with Ralf Jaeger, Martin Purpura, and Kylin Liao.
“We’re very excited about this ingredient, which is upstaging the gold-standard for the last hundred years,” Wells told NutraIngredients-USA at the recent SupplySide West in Las Vegas.
Wells explained that the company was exploring the potential of the PEPT1 transporter in the gut, a transporter that preferentially chooses di- and tri- peptides over single amino acids.
“The thought was, ‘OK, leucine turns on muscle protein synthesis and it’s not about the amount of leucine that you orally consume, it’s about how quickly it goes up in the plasma’. The idea was to do a di- or tri-peptide of leucine and would it be better than leucine itself? And that’s what we saw, and that’s groundbreaking.”
'This ingredient is upstaging the gold-standard': ING2 co-founder on excitement around dileucine - NutraIngredients-usa.com
Read More
No comments:
Post a Comment